Show simple item record

In vitro thymosin effect on T lymphocytes in alcoholic liver disease

dc.contributor.authorMutchnick, Milton G.en_US
dc.contributor.authorGoldstein, Allan L.en_US
dc.date.accessioned2006-04-07T17:36:35Z
dc.date.available2006-04-07T17:36:35Z
dc.date.issued1979-03en_US
dc.identifier.citationMutchnick, Milton G., Goldstein, Allan L. (1979/03)."In vitro thymosin effect on T lymphocytes in alcoholic liver disease." Clinical Immunology and Immunopathology 12(3): 271-280. <http://hdl.handle.net/2027.42/23618>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6WCK-4BMD49B-P0/2/c1b2129880ad7a4d7ad728019f2fefdaen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/23618
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=313287&dopt=citationen_US
dc.description.abstractThe in vitro effect of thymosin fraction 5, a thymic gland extract, on thymus-dependent lymphocytes was studied in 12 patients with alcoholic hepatitis (AH) and in 18 patients with compensated alcoholic cirrhosis (CAC). The baseline number and proportion of spontaneous rosette-forming T lymphocytes were significantly reduced in AH as compared to the controls. No such decrease was seen in CAC. When the lymphocytes of patients with AH were incubated in the presence of thymosin fraction 5, the subsequent number and proportion of rosette-forming T lymphocytes showed a significant increase. There was no significant reponse to thymosin in CAC or in control subjects. There appears to be a subset of immature T lymphocytes in patients with AH that is responsive to exogenous thymic factors with subsequent activation of the capacity to form spontaneous rosettes.en_US
dc.format.extent639207 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleIn vitro thymosin effect on T lymphocytes in alcoholic liver diseaseen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMicrobiology and Immunologyen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumResearch Service, Veterans Administration Hospital, Ann Arbor, Michigan 48105, USA; Department of Medicine, University of Michigan, Ann Arbor, Michigan 49105, USAen_US
dc.contributor.affiliationotherDepartment of Biochemistry, George Washington University Medical Center, Washington, D.C. 20037, USAen_US
dc.identifier.pmid313287en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/23618/1/0000581.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0090-1229(79)90030-8en_US
dc.identifier.sourceClinical Immunology and Immunopathologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.